Form D · Biotechnology
SILVER MEDICAL INC
Palo Alto, CA · CIK 0001426627
Offering snapshot reported Jan 13, 2011 · SEC filing
- Reported sold
- $45K Offering amount: $45K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2011 | Initial | $45,045 | No comparison | 2 | SEC filing |
| Feb 6, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-153693
Convertible Promissory Notes and Stock Purchase Warrants (including (i) the shares of Preferred Stock issuable upon conversion of the Notes and upon exercise of the Warrants and (ii) the shares of Common Stock issuable upon conversion of the Preferred Sto
Source: Form D, filed Jan 13, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Silver | Director, Executive |
| Erik Van Der Burg | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
45 Roosevelt Circle
Palo Alto, CA, 94306
Palo Alto, CA, 94306